Endoglim M1 Tablet PR
By Endoglim M
Rx
15 Tablet PR in a Strip

Composition
Glimepiride(1mg) + Metformin(1000mg)

Manufacturer - Arkas Pharma Pvt Ltd
H.NO.1-4-180/80/A, SAI BABA OFFICERS COLONY, SAINIKPURI KAPRA HYDERABAD TG 500094 IN , - , .

Expires on or after
August, 2025

liver
When using Endoglim M1 Tablet PR, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking this medication. It is advisable to consult your doctor before starting treatment with Endoglim M1 Tablet PR. Typically, this medication is initiated at a low dose for individuals with mild to moderate liver disease. However, it is not recommended for use in patients with severe liver disease.

kidney
Endoglim M1 Tablet PR needs caution in kidney disease. Dosage adjustment may be necessary. Avoid in severe kidney disease. Regular kidney function tests are recommended during use. Consulting your doctor is essential.

alcohol
It is not recommended to drink alcohol while taking Endoglim M1 Tablet PR. Please avoid alcohol consumption with this medication. Caution should be taken during pregnancy.

driving
Driving while taking Endoglim M1 Tablet PR can be risky if your blood sugar is too low or high. Avoid driving if you have these symptoms to ensure safety.

pregnancy
Endoglim M1 Tablet PR may not be safe to use during pregnancy. Limited human studies and animal studies have shown potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing it. Please consult your doctor.

breastfeeding
Caution should be exercised during breastfeeding as Endoglim M1 Tablet PR is not recommended. It may pose a risk of toxicity to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹123.75
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024